Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Digital Biomanufacturing Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The digital biomanufacturing market has experienced rapid expansion in recent years. This market is projected to expand from $23.97 billion in 2025 to $27.25 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.6%. Historically, this growth has been driven by factors including the increasing production of biologics, the imperative for enhanced process efficiency, the widespread adoption of automation in pharmaceutical manufacturing, a heightened regulatory focus on quality compliance, and the escalating complexity of manufacturing operations.
The market for digital biomanufacturing is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $46.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.0%. This projected increase is driven by factors such as the expanding field of cell and gene therapies, the embrace of continuous manufacturing processes, the incorporation of AI into bioprocessing, the necessity for quicker product launches, and increased investment in intelligent biomanufacturing infrastructure. Key developments expected during this timeframe encompass data-driven optimization of bioprocesses, the automation of biomanufacturing tasks, the implementation of digital twin technology, continuous real-time process oversight, and AI-powered quality control mechanisms.
Get A Free Sample Report With In-Depth Market Insights:
Digital Biomanufacturing Market Development Factors: What’s Supporting Demand?
The expanding pharmaceutical sector is poised to fuel the advancement of digital biomanufacturing. This industry is crucial for healthcare, focusing on the research, development, and production of medicines to ensure the availability of safe and effective treatments. Its expansion is attributed to increasing global demand for healthcare and medications, influenced by a larger and aging population, which necessitates greater production and innovation in drug development to address evolving medical requirements. Digital biomanufacturing supports the pharmaceutical industry by integrating advanced data analytics, automation, and real-time monitoring to streamline drug production, elevate quality control, decrease manufacturing expenses, and accelerate the creation of safe and effective therapies. For instance, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA) in November 2024, North America was responsible for 54.8% of estimated world pharmaceutical sales in 2024, compared to 22.7% for Europe. Additionally, in 2024, an estimated €55,000 million was invested in R&D in Europe. Therefore, the growing pharmaceutical industry acts as a primary driver for the digital biomanufacturing market.
Digital Biomanufacturing Market Segment Outlook: Which Categories Are Growing Fastest?
The digital biomanufacturing market covered in this report is segmented –
1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And Internet Of Things (IoT) Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing
Digital Biomanufacturing Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the digital biomanufacturing market are concentrating on developing innovative technologies, such as single-use bioreactors, to enhance process efficiency, scalability, and flexibility in biologics production. Single-use bioreactors are defined as a type of bioreactor specifically designed for one-time applications in biomanufacturing, thereby eliminating the need for cleaning and sterilization between batches. These bioreactors also offer increased flexibility, reduce contamination risks, and streamline the production of biologics and vaccines. For example, in March 2025, the European Commission, a Belgium-based government agency, launched the Biotech and Biomanufacturing Hub. This dedicated online platform aims to support biotech and biomanufacturing companies across the EU, especially startups and SMEs, by providing single-point access to funding programs, regulatory guidance, intellectual property support, pilot and testing infrastructure, and networking tools. The hub also serves as a crucial component of the Commission’s “Boosting Biotechnology and Biomanufacturing in the EU” strategy, which is designed to strengthen Europe’s biotech ecosystem, increase competitiveness, reduce dependence on external supply chains, and streamline the journey from innovation to commercialization for biotech-based products.
Digital Biomanufacturing Market Leading Companies And Competitive Benchmarking
Major companies operating in the digital biomanufacturing market are Sanofi SA; Thermo Fisher Scientific Inc.; Honeywell International Inc.; SAP SE; Danaher Corporation; ABB AG; Siemens Healthineers AG; Emerson Electric Co; GE HealthCare Technologies Inc.; Atos SE; Agilent Technologies Inc.; Cytiva Europe GmbH; Lonza Group AG; Dassault Systèmes SE; Sartorius AG; Pall Corporation; Eppendorf AG; Symphony Innovation LLC; Koch Membrane Systems Inc.; Culture Biosciences Inc.; Bota Biosciences Inc.; Shimadzu Corporation; e-MSion; Immersciobio GmbH
View The Full Digital Biomanufacturing Market Report:
Digital Biomanufacturing Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the digital biomanufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
